Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-05-03
2011-05-03
Maier, Leigh C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S128000
Reexamination Certificate
active
07935684
ABSTRACT:
The present invention relates to use of polysaccharides obtained fromDendrobiumfor treating an allergic disease or for reducing airway-remodeling caused by inflammation.
REFERENCES:
patent: 6586403 (2003-07-01), Mathison et al.
patent: 2006/0251739 (2006-11-01), Wu
Mizushima, Y. et al “Oral adminstration of leflunomide . . . ” J. Pharmacol. Exp. Ther. (1999) vol. 288, No. 2, pp. 849-857.
Zha et al., “Structure identification of a new immunostimulating polysaccharide from the stems ofDendrobium huoshanense” Carbohydrate Polymers 69 (2007) 86-93.
Ko et al., “Enhancement of ATP generation capacity, antioxidant activity and immunomodulatory activities by Chinese Yang and Yin tonifying herbs” Chinese Medicine 2007, 2:3.
Zhao et al., “Antioxidant and Anti-hyperglycemic Activity of Polysaccharide Isolated fromDendrobium chrysotoxumLindl” Journal of Biochemistry and Molecular Biology, vol. 40, No. 5, Sep. 2007, pp. 670-677.
Clark, “Omalizumab in the Treatment of Allergic Respiratory Disease”, Journal of Asthma, 43:87-93, 2006.
Cooper, “Intestinal Worms and Human Allergy”, Parasite Immunology, 2004, 26, 455-467.
Holgate, “The Anti-inflammatory Effects of Omalizumab Confirm the Central Role of IgE in Allergic Inflammation”, 2005 American Academy of Allergy, Asthma and Immunology, J. Allergy Clin Immunol, vol. 115, No. 4.
Lilly, “Diversity of Asthma: Evolving Concepts of Pathophysiology and Lessons from Genetics”, 2005 American Academy of Allergy, Asthma and Immunology doi:10.1016/j.jaci.2005.01.028.
Menzies-Gow, “Eosinophil Chemokines and Chemokine Receptors: Their Role in Eosinophil Accumulation and Activation in Asthma and Potential as Therapeutic Targets”, Journal of Asthma, 38(8), 605-613 (2001).
Milgrow, “Treatment of Allergic Asthma With Monoclonal Anti-IgE Antibody”, New England Journal of Medicine, vol. 341, No. 26, Dec. 23, 1999.
Perkins, “IL-4 Induces IL-13-independent Allergic Airway Inflammation”, J. Allergy Clin Immunol, vol. 118, No. 2, (2006).
Platts-Mills, “The Role of Immunoglobulin E in Allergy and Asthma”, American Journal of Respiratory and Critical Care Medicine, vol. 164, 2001.
Satoh, “Specific Inhibition of Na+,K+ATPase Activity by Atractylon, a Major Component of Byaku-jutsu, by Interaction with Enzyme in the E2State”,Biochemical Pharmacology, vol. 51, pp. 339-343, 1996. Copyright © 1996 Elsevier Science Inc.
Odemuyiwa, “Cutting Edge: Human Eosinophils Regulate T Cells Subset Selection through Indoleamine 2,3-Dioxygenase”, The Journal of Immunology, 2004, 5909-5913.
Rothenberg, “Mechanisms of Disease”, The New England Journal of Medicine, May 28, 1998, 1592-1600.
Sarinho, “Anti-IgE monoclonal antibody for the treatment of asthma and other manifestations related to allergic diseases”, Jornal de Pediatrai—vol. 82, No. 5 (Suppl), 2006.
Schopf, “Differential Moducation of Allergic Eye Disease by Chronic and Acute Ascaris Infection”, Investigative Opthalmology & Visual Science, Aug. 2005, vol. 46, No. 8.
Sumi, “Thymus-Derived CD4+CD25+T Cells Suppress the Development of Murine Allergic Conjunctivities”, Int Arch Allergy Immunol 2007; 143:376-281.
Wagelie-Steffen, “Biologic Therapies for the Treatment of Asthma”, Clin Chest Med 27 (2006) 133-147.
Walsh, “Eosinophil Granule Proteins and their Role in Disease”, Current Opinion in Hematology 2001, 8:28-33.
Yamaguchi, “Antioxidant Activity of the Extracts from Fruiting Bodies of Cultured Cordyceps Sinensis”, Phytotherapy Research, Rphyother, Res. 14, 647-649 (2000).
Zhang, “Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride power”, J. Allergy Clin Immunol, vol. 113, No. 2, (2004).
Zhao, “Antioxidant and Anti-hyperglycemic Activity of Polysaccharide Isolated from Dendrobium chrysotoxum Lindl”, Journal of Biochemistry and Molecular Biology, vol. 40, No. 5, Sep. 2007, pp. 670-677.
Intellectual Property Connections, Inc.
Maier Leigh C
National Yang-Ming University
Saunders Hsiu-Ming
LandOfFree
Method for treating allergic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating allergic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating allergic diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643275